CryoLife Stock Price and Value Analysis

Should you buy CryoLife stock? (NYSE:CRY). Let's see how it does in our automated value investing analysis system.

CRY Free Cash Flow Trend

Free Cash Flow trendline for CRY
Free Cash Flow trendline for CryoLife

Based on historical returns, we believe that CryoLife can grow its free cash at a rate of about 1%. That's positive!

  • This company is solid.
  • This company has wild ups and downs.
  • This company is making money at a modest rate.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the CRY Numbers

CRY Price
(CryoLife stock price per share)
[?] CRY Fair Price
(based on intrinsic value)
[?] CRY Safety Price (based on a variable margin of safety) $6.14
[?] PE Ratio versus Sector 1343% higher than other Healthcare stocks
[?] PE Ratio versus Industry 263% higher than other Medical Devices stocks
[?] Cash Yield 1.33%
[?] Free Cash Flow Jitter 91%

Is CryoLife Stock on Sale?

We believe that CryoLife may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

CryoLife looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy CRY Stock?

Does CryoLife have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.